Screener
Bristol-Myers Squibb BMY Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by Bristol-Myers Squibb in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: Bristol-Myers Squibb’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 11:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000014272-26-000020
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Net product sales | $12,588 | $11,909 | $23,756 | $22,794 |
| Alliance and other revenues | 385 | 360 | 706 | 676 |
| Total Revenues | 12,973 | 12,269 | 24,462 | 23,470 |
| Cost of products sold(a) | 3,726 | 3,372 | 7,146 | 6,404 |
| Selling, general and administrative | 1,826 | 1,713 | 3,443 | 3,297 |
| Research and development | 2,959 | 2,580 | 5,608 | 4,837 |
| Acquired IPRD | — | 1,508 | 94 | 1,695 |
| Amortization of acquired intangible assets | 437 | 830 | 874 | 1,660 |
Item 1. FINANCIAL STATEMENTS
FAQ
- What is Bristol-Myers Squibb's total revenue?
- Bristol-Myers Squibb (BMY) reported total revenue of $12.97B in Q2 2026.
- How has Bristol-Myers Squibb's total revenue changed year-over-year?
- Bristol-Myers Squibb's total revenue increased by 5.7% year-over-year, from $12.27B to $12.97B.
- What is the long-term trend for Bristol-Myers Squibb's total revenue?
- Over 4 years (2021 to 2025), Bristol-Myers Squibb's total revenue has grown at a 1.0% compound annual growth rate (CAGR), from $46.39B to $48.19B.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Bristol-Myers Squibb's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude